3BP has become a leading player in the discovery and development of innovative radiopharmaceutical cancer medicines and diagnostics. Building on its core expertise in peptide drug discovery 3BP has developed a broad product pipeline of which several programs have been successfully licensed out to international pharmaceutical companies. 3BP is using ActivityBase as its central research data repository which is queried via SARview/SARgen.